
In this free webinar, learn how a science- and risk-based lyophilization strategy can improve product stability and support scale-up. The featured speaker will discuss formulation and cycle development, thermal characterization, process analytical technology and monitoring approaches for freeze-drying. Attendees will also explore how stronger process understanding can reduce cycle time, address scale-up challenges and support regulatory readiness.
TORONTO, Oct. 19, 2026 /PRNewswire/ -- Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors, peptides, proteins and hydrolytically sensitive small-molecule injectables. For many of these modalities, limited aqueous stability can affect shelf life, distribution and commercial viability. This webinar explores a science- and risk-based lyophilization by design approach to developing robust, scalable and regulatory-ready freeze-drying processes.
Participants will gain a practical understanding of the three key stages of lyophilization: freezing, primary drying and secondary drying and how each stage influences product temperature, cake structure, residual moisture and long-term stability. The session will also examine critical thermal properties, including glass-transition and collapse temperatures, using techniques such as differential scanning calorimetry and freeze-drying microscopy.
The webinar will cover formulation–cycle co-development, lyoprotectant and bulking agent selection, heat- and mass-transfer considerations, design of experiments, ICH Q8(R2)-aligned design-space development and Process Analytical Technology (PAT). It will also examine monitoring approaches for establishing science-based drying endpoints and reduce unnecessary cycle time.
Common development and scale-up challenges, including cake collapse, inadequate drying, excessive residual moisture, vial-to-vial variability, poor process transferability and incomplete CMC justification, will be discussed alongside practical mitigation strategies. A representative case study will demonstrate how systematic cycle optimization reduced total cycle duration from 120 to 95 hours while maintaining critical quality attributes and improving potential manufacturing throughput.
The session will connect these development decisions with GMP scale-up, technology transfer and regulatory considerations, demonstrating how greater process understanding can support consistency throughout the product lifecycle.
Register for this webinar to learn how lyophilization by design can reduce cycle time, strengthen process robustness and support regulatory-ready scale-up.
Join M.S. Vijaykanth, PhD, SVP & Head – R&D, OneSource Specialty Pharma, for the live webinar scheduled as two broadcasts on: Tuesday, November 3, 2026, at 1pm EST (7pm CET / EU-Central) and Thursday, November 26, 2026, at 8am EST (2pm CET / EU-Central).
For more information, or to register for this event, visit Lyophilization by Design: Improve Stability and Accelerate Scale-Up (Broadcast 1).
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks
Share this article